Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans

RC Kessler, 2009, The WHO World Mental Health (WMH) Surveys, Psychiatrie (Stuttg), 6, 5

JR Geddes, 2013, Treatment of bipolar disorder, Lancet, 381, 1672, 10.1016/S0140-6736(13)60857-0

T Klengel, 2013, Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions, Nat Neurosci, 16, 33, 10.1038/nn.3275

BK Attwood, 2011, Neuropsin cleaves EphB2 in the amygdala to control anxiety, Nature, 473, 372, 10.1038/nature09938

J Hartmann, 2012, The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress, Neuropharmacology, 62, 332, 10.1016/j.neuropharm.2011.07.041

C Touma, 2011, FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior, Biol Psychiatry, 70, 928, 10.1016/j.biopsych.2011.07.023

GM Wochnik, 2005, FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells, J Biol Chem, 280, 4609, 10.1074/jbc.M407498200

EB Binder, 2004, Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment, Nat Genet, 36, 1319, 10.1038/ng1479

M Lekman, 2008, The FKBP5-gene in depression and treatment response—an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort, Biol Psychiatry, 63, 1103, 10.1016/j.biopsych.2007.10.026

YF Zou, 2010, Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders, Neurosci Lett, 484, 56, 10.1016/j.neulet.2010.08.019

G Laje, 2009, Pharmacogenetics studies in STAR*D: strengths, limitations, and results, Psychiatr Serv, 60, 1446, 10.1176/ps.2009.60.11.1446

ER De Kloet, 2005, Stress and the brain: from adaptation to disease, Nat Rev Neurosci, 6, 463, 10.1038/nrn1683

F Holsboer, 2000, The corticosteroid receptor hypothesis of depression, Neuropsychopharmacology, 23, 477, 10.1016/S0893-133X(00)00159-7

J Zschocke, 2011, Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons—dissociation from cholesterol homeostasis, Neuropsychopharmacology, 36, 1754, 10.1038/npp.2011.57

M Rossi, 2009, Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux, J Cell Sci, 122, 3330, 10.1242/jcs.048181

M Taipale, 2010, HSP90 at the hub of protein homeostasis: emerging mechanistic insights, Nat Rev Mol Cell Biol, 11, 515, 10.1038/nrm2918

N Mizushima, 2011, Autophagy: renovation of cells and tissues, Cell, 147, 728, 10.1016/j.cell.2011.10.026

H Nakatogawa, 2009, Dynamics and diversity in autophagy mechanisms: lessons from yeast, Nat Rev Mol Cell Biol, 10, 458, 10.1038/nrm2708

RC Wang, 2012, Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation, Science, 338, 956, 10.1126/science.1225967

H Harris, 2012, Control of autophagy as a therapy for neurodegenerative disease, Nat Rev Neurol, 8, 108, 10.1038/nrneurol.2011.200

B Levine, 2008, Autophagy in the pathogenesis of disease, Cell, 132, 27, 10.1016/j.cell.2007.12.018

L Welberg, 2012, Neurotransmission: autophagy regulates transmission, Nat Rev Neurosci, 13, 362, 10.1038/nrn3266

Q Cai, 2010, Snapin-regulated late endosomal transport is critical for efficient autophagy-lysosomal function in neurons, Neuron, 68, 73, 10.1016/j.neuron.2010.09.022

J Ma, 2013, Antidepressant desipramine leads to C6 glioma cell autophagy: implication for the adjuvant therapy of cancer, Anticancer Agents Med Chem, 13, 254, 10.2174/1871520611313020011

J Chen, 2012, Accumulation of an antidepressant in vesiculogenic membranes of yeast cells triggers autophagy, PLoS ONE, 7, e34024, 10.1371/journal.pone.0034024

NZ Kara, 2013, Trehalose induced antidepressant-like effects and autophagy enhancement in mice, Psychopharmacology (Berl), 229, 367, 10.1007/s00213-013-3119-4

C Cleary, 2008, Antidepressive-like effects of rapamycin in animal models: implications for mTOR inhibition as a new target for treatment of affective disorders, Brain Res Bull, 76, 469, 10.1016/j.brainresbull.2008.03.005

EJ Nestler, 2010, Animal models of neuropsychiatric disorders, Nat Neurosci, 13, 1161, 10.1038/nn.2647

JM Deussing, 2006, Animal models of depression, Drug Discov Today, 3, 375

XD Wang, 2011, Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling, Neurobiol Dis, 42, 300, 10.1016/j.nbd.2011.01.020

O Berton, 2006, Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress, Science, 311, 864, 10.1126/science.1120972

JE Skeen, 2006, Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner, Cancer Cell, 10, 269, 10.1016/j.ccr.2006.08.022

T Perisic, 2010, Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes, Neuropsychopharmacology, 35, 792, 10.1038/npp.2009.188

B Franke, 1998, CNS glia are targets for GDNF and neurturin, Histochem Cell Biol, 110, 595, 10.1007/s004180050322

BG Schumann, 2011, Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters, Mol Biochem Parasitol, 175, 91, 10.1016/j.molbiopara.2010.09.002

D Kim, 2010, A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation, J Biol Chem, 285, 8383, 10.1074/jbc.M109.094060

A Brunet, 1999, Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor, Cell, 96, 857, 10.1016/S0092-8674(00)80595-4

Y Kabeya, 2000, LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing, EMBO J, 19, 5720, 10.1093/emboj/19.21.5720

KV Wagner, 2012, Differences in FKBP51 regulation following chronic social defeat stress correlate with individual stress sensitivity: influence of paroxetine treatment, Neuropsychopharmacology, 37, 2797, 10.1038/npp.2012.150

KV Wagner, 2011, Pituitary glucocorticoid receptor deletion reduces vulnerability to chronic stress, Psychoneuroendocrinology, 36, 579, 10.1016/j.psyneuen.2010.09.007

KL McIlwain, 2001, The use of behavioral test batteries: effects of training history, Physiol Behav, 73, 705, 10.1016/S0031-9384(01)00528-5

SA Golden, 2011, A standardized protocol for repeated social defeat stress in mice, Nat Protoc, 6, 1183, 10.1038/nprot.2011.361

M Fluttert, 2000, A refined method for sequential blood sampling by tail incision in rats, Lab Anim, 34, 372, 10.1258/002367700780387714

M Uhr, 2000, Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption, Neuropsychopharmacology, 22, 380, 10.1016/S0893-133X(99)00095-0

M Uhr, 2003, Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption, Biol Psychiatry, 54, 840, 10.1016/S0006-3223(03)00074-X

JM Hennings, 2009, Clinical characteristics and treatment outcome in a representative sample of depressed inpatients—findings from the Munich Antidepressant Response Signature (MARS) project, J Psychiatr Res, 43, 215, 10.1016/j.jpsychires.2008.05.002

American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edition. Washington (District of Columbia): American Psychiatric Association.

JE Overall, 1982, Use of the Hamilton Rating Scale for classification of depressive disorders, Compr Psychiatry, 23, 370, 10.1016/0010-440X(82)90087-6

C Hiemke, 2011, AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011, Pharmacopsychiatry, 44, 195, 10.1055/s-0031-1286287

BG Taksande, 2009, Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine, Neuropharmacology, 57, 415, 10.1016/j.neuropharm.2009.06.035

CK Thoeringer, 2010, Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice, J Psychopharmacol, 24, 733, 10.1177/0269881109103091

N Galeotti, 2012, Selective modulation of the PKCvarepsilon/p38MAP kinase signalling pathway for the antidepressant-like activity of amitriptyline, Neuropharmacology, 62, 289, 10.1016/j.neuropharm.2011.07.020

H Pei, 2009, FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt, Cancer Cell, 16, 259, 10.1016/j.ccr.2009.07.016

DJ Klionsky, 2012, Guidelines for the use and interpretation of assays for monitoring autophagy, Autophagy, 8, 445, 10.4161/auto.19496

SH Jeon, 2011, The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells, Biochem Biophys Res Commun, 413, 311, 10.1016/j.bbrc.2011.08.093

W Huang, 2013, Fluoxetine upregulates phosphorylated-AKT and phosphorylated-ERK1/2 proteins in neural stem cells: evidence for a crosstalk between AKT and ERK1/2 pathways, J Mol Neurosci, 49, 244, 10.1007/s12031-012-9822-5

N Li, 2010, mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists, Science, 329, 959, 10.1126/science.1190287

B Voleti, 2013, Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses, Biol Psychiatry, 74, 742, 10.1016/j.biopsych.2013.04.025

TR Hubler, 2004, Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids, Cell Stress Chaperones, 9, 243, 10.1379/CSC-32R.1

E Laane, 2009, Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy, Cell Death Differ, 16, 1018, 10.1038/cdd.2009.46

JG Scammell, 2001, Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates, Gen Comp Endocrinol, 124, 152, 10.1006/gcen.2001.7696

MS Bhuiyan, 2011, Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding, Eur J Pharmacol, 650, 621, 10.1016/j.ejphar.2010.10.055

A Basta-Kaim, 2005, Inhibitory effect of imipramine on the human corticotropin-releasing-hormone gene promoter activity operates through a PI3-K/AKT mediated pathway, Neuropharmacology, 49, 156, 10.1016/j.neuropharm.2005.02.008

BD Manning, 2007, AKT/PKB signaling: navigating downstream, Cell, 129, 1261, 10.1016/j.cell.2007.06.009

O Berton, 2006, New approaches to antidepressant drug discovery: beyond monoamines, Nat Rev Neurosci, 7, 137, 10.1038/nrn1846

D Hernandez, 2012, Regulation of presynaptic neurotransmission by macroautophagy, Neuron, 74, 277, 10.1016/j.neuron.2012.02.020

CS Kim, 2012, Enhancement of dorsal hippocampal activity by knockdown of HCN1 channels leads to anxiolytic- and antidepressant-like behaviors, Neuron, 75, 503, 10.1016/j.neuron.2012.05.027

JC O'Leary 3rd, 2011, A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51, PLoS ONE, 6, e24840, 10.1371/journal.pone.0024840

UK Jinwal, 2010, The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules, J Neurosci, 30, 591, 10.1523/JNEUROSCI.4815-09.2010

AL Barabasi, 2011, Network medicine: a network-based approach to human disease, Nat Rev Genet, 12, 56, 10.1038/nrg2918

L Luo, 2008, Genetic dissection of neural circuits, Neuron, 57, 634, 10.1016/j.neuron.2008.01.002